Cargando…

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells

BACKGROUND: STAT3 activation is frequently detected in breast cancer and this pathway has emerged as an attractive molecular target for cancer treatment. Recent experimental evidence suggests ALDH-positive (ALDH(+)), or cell surface molecule CD44-positive (CD44(+)) but CD24-negative (CD24(−)) breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Li, Hutzen, Brian, Lee, Hsiu-Fang, Peng, Zhengang, Wang, Wenlong, Zhao, Chongqiang, Lin, Huey-Jen, Sun, Duxin, Li, Pui-Kai, Li, Chenglong, Korkaya, Hasan, Wicha, Max S., Lin, Jiayuh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871589/ https://www.ncbi.nlm.nih.gov/pubmed/24376586 http://dx.doi.org/10.1371/journal.pone.0082821

Ejemplares similares

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44(+)/CD24(−) and ALDH1(+)): Prognostic Implications in Invasive Breast Cancer()()
por: Riaz, Nazia, et al.
Publicado: (2018)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

Different Biological Action of Oleic Acid in ALDH(high) and ALDH(low) Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer
por: Kim, Hoe Suk, et al.
Publicado: (2016)

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

CD44+/EPCAM+ cells detect a subpopulation of ALDH(high) cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?
por: Masciale, Valentina, et al.
Publicado: (2020)

A New Strategy Using ALDH(high)-CD8+T Cells to Inhibit Tumorigenesis
por: Luo, Huiyan, et al.
Publicado: (2014)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis
por: Pan, Meng, et al.
Publicado: (2021)

The expression of ALDH1 in cervical carcinoma
por: Yao, Tingting, et al.
Publicado: (2011)

Immunohistochemical Expression of CD(56) and ALDH(1 )in Common Salivary Gland Tumors
por: Seifi, Safoura, et al.
Publicado: (2016)

ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44(+)/CD24(–/low) stem cells in different molecular subtypes of breast cancer
por: Chen, Jie, et al.
Publicado: (2020)

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity
por: Cortes-Dericks, Lourdes, et al.
Publicado: (2014)

Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
por: Jakob, Mark, et al.
Publicado: (2020)

A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activators
por: Chang, Yi-Cheng, et al.
Publicado: (2023)

The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
por: Ball, Sarah, et al.
Publicado: (2011)

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
por: Strati, Areti, et al.
Publicado: (2019)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH(High) Melanoma-Initiating Cells
por: Sarvi, Sana, et al.
Publicado: (2018)

ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy
por: Javed, Shifa, et al.
Publicado: (2021)

A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells
por: Zhao, Chongqiang, et al.
Publicado: (2016)

Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45(+)CD19(-) cells but in the ALDH(high) Cells
por: Song, Shupeng, et al.
Publicado: (2020)

The roles of aldehyde dehydrogenases (ALDHs) in the PDH bypass of Arabidopsis
por: Wei, Yanling, et al.
Publicado: (2009)

The Role of Alcohol, LPS Toxicity, and ALDH2 in Dental Bony Defects
por: Tsai, Hsiao-Cheng, et al.
Publicado: (2021)

Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment
por: Zhang, Hong, et al.
Publicado: (2021)

A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations
por: Canino, Claudia, et al.
Publicado: (2015)

Abnormal expression of the Notch and Wnt/β-catenin signaling pathways in stem-like ALDH(hi)CD44(+) cells correlates highly with Ki-67 expression in breast cancer
por: CUI, JUNWEI, et al.
Publicado: (2015)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

ALDH2 variance in disease and populations
por: Chen, Che-Hong, et al.
Publicado: (2022)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

ALDH1 might influence the metastatic capability of HeLa cells
por: Yao, Tingting, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3sdfa437e586malhcmbl56r8ni